Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of blood thinners on efficacy of ALTA injection sclerotherapy for bleeding hemorrhoids
jRCT1030220379Active, not recruiting
- Sponsor
- Takaaki Yano
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ALTA in hemorrhoid, sponsored by Takaaki Yano. Primary endpoint: One-year composite outcome of symptoms and satisfaction. Started Jun 2013; status: active, not recruiting.
02
Drugs
ALTA
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on jRCT1030220379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030220379.